Skip to content
    Shinhan Capital logo

    Shinhan Capital

    Seoul, South KoreaFounded 1991

    Shinhan Capital is a credit finance corporation and subsidiary of Shinhan Financial Group, founded in 1991 and headquartered in Seoul, South Korea. The firm engages in venture capital, private equity, mezzanine investments, M&A financing, and corporate lending, with investments spanning software, biotechnology, and financial services.

    Average disclosed round size is $122.2M (across 32 rounds with reported amounts).

    Find people at Shinhan Capital on Goldilocks AI

    Portfolio

    34

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    JH

    Joon-Ki Hong

    Associate

    JK

    Justin Kim

    Analyst

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    42 investments
    CompanyRoundAmountDate
    EEnventricIpo—Jun 2026
    Open Asset logoOpen AssetSeed—Jan 2026
    Zordi logoZordiSeries B—May 2025
    trioar logotrioarSeries B$16MJan 2025
    Avelos Therapeutics logoAvelos TherapeuticsSeries B$12.3MApr 2024
    Avelos Therapeutics logoAvelos TherapeuticsSeries A$8MJan 2024
    Maka Motors logoMaka MotorsSeed$37.6MJul 2023
    EnergyX logoEnergyXSeries B$20.3MJan 2023
    IM Biologics logoIM BiologicsSeries B$2.0MJan 2023
    Nearthlab logoNearthlabSeries B—Jan 2023
    WWemadeUnknown$46MNov 2022
    AutoCrypt logoAutoCryptSeries B$25.5MMay 2022
    ReCon Labs Inc. logoReCon Labs Inc.Series A$4.4MMay 2022
    ReCon Labs Inc. logoReCon Labs Inc.Unknown$4.4MMay 2022
    Xangle logoXangleSeries B$17MJan 2022
    Recon logoReconSeries A—Jan 2022
    Lambda256 logoLambda256Series B—Dec 2021
    42dot logo42dotSeries A$88.5MNov 2021
    Fount logoFountSeries C$33.4MOct 2021
    Fount logoFountSeries C$33.4MOct 2021
    Fount logoFountSeries C$33.4MOct 2021
    Wave logoWaveSeries A$200MSep 2021
    AAffyXell TherapeuticsSeries A$7.3MFeb 2021
    Motion2AI logoMotion2AISeries A$12.6MJan 2021
    DDexlevo, Inc.Unknown—Jan 2021
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026